FDA Inspection 1219052 — HR Pharmaceuticals, Inc
The FDA completed an inspection of HR Pharmaceuticals, Inc on August 30, 2023 in York, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 30, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- York, PA (United States)